New Two-Drug combo tested for mysterious cancers
NCT ID NCT06754501
Summary
This study is testing whether a combination of two immunotherapy drugs, atezolizumab and tiragolumab, can help control cancer of unknown primary. It is for adults whose cancer has spread and who have already tried or cannot have standard chemotherapy. The main goals are to see if the treatment shrinks tumors and to monitor its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.